332TiP SOLTI-1907 ATREZZO: Targeting hormonal receptor negative (HR-) or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2+ metastatic breast cancer (MBC)Eva Ciruelos,Sonia Pernas,Antonia Perelló,Aurelio López,F.J. Salvador Bofill,J.M. Cejalvo,Isabel Blancas,J. Ponce Lorenzo,Sonia Servitja,Martínez Pérez,Josefina Cruz,C. Albacar,Santiago Escrivá-de-Romaní,Juan Antonio Guerra,Santiago González-Santiago,Esther Sanfeliu,Cristina Rodríguez,P. Tolosa,Juan M Ferrero-Cafiero,Aleix PratAnnals of Oncology(2021)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要